symbol,statement_type,period_end,line_item,value
SHILPAMED.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,-101084445.683868
SHILPAMED.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.359969
SHILPAMED.NS,income,2025-03-31 00:00:00,Normalized EBITDA,3389397000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Total Unusual Items,-280814000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-280814000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,782930000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,1129925000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,4103707000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,EBITDA,3108583000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,EBIT,1978658000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Interest Income,-755329000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Interest Expense,755329000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Interest Income,
SHILPAMED.NS,income,2025-03-31 00:00:00,Normalized Income,962659554.316132
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,782930000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Total Expenses,10823548000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
SHILPAMED.NS,income,2025-03-31 00:00:00,Diluted Average Shares,97379229.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Basic Average Shares,97379229.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Diluted EPS,8.04
SHILPAMED.NS,income,2025-03-31 00:00:00,Basic EPS,8.04
SHILPAMED.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,782929000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,782929000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,1000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income,782930000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Minority Interests,-38000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,782968000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,782968000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Tax Provision,440361000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Pretax Income,1223329000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,231534000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Special Income Charges,-280814000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Other Special Charges,290977000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Write Off,-10163000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-755329000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
SHILPAMED.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,755329000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
SHILPAMED.NS,income,2025-03-31 00:00:00,Operating Income,2040593000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Operating Expense,6719841000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2662824000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,1129925000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,1129925000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Research And Development,
SHILPAMED.NS,income,2025-03-31 00:00:00,Selling General And Administration,
SHILPAMED.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
SHILPAMED.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
SHILPAMED.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
SHILPAMED.NS,income,2025-03-31 00:00:00,Gross Profit,8760434000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Cost Of Revenue,4103707000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Total Revenue,12864141000.0
SHILPAMED.NS,income,2025-03-31 00:00:00,Operating Revenue,12864141000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,18392100.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
SHILPAMED.NS,income,2024-03-31 00:00:00,Normalized EBITDA,2478893000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Total Unusual Items,61307000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,61307000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,318743000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,1078699000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,4075539000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,EBITDA,2540200000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,EBIT,1461501000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Interest Income,-918094000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Interest Expense,918094000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Interest Income,13841000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Normalized Income,275828100.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,318743000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Total Expenses,10149758000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,12536000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Diluted Average Shares,86850681.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Basic Average Shares,86850681.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Diluted EPS,3.67
SHILPAMED.NS,income,2024-03-31 00:00:00,Basic EPS,3.67
SHILPAMED.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,318742000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,318742000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,1000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income,318743000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Minority Interests,-809000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,319552000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,319552000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Tax Provision,223855000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Pretax Income,543407000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,81705000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Special Income Charges,61307000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Other Special Charges,-61307000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Write Off,47209000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-918094000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,80805000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,918094000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,13841000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Operating Income,1366272000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Operating Expense,6074219000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2180589000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,1078699000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,1078699000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Research And Development,309558000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Selling General And Administration,247035000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,28681000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,General And Administrative Expense,218354000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,12536000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Gross Profit,7440491000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Cost Of Revenue,4075539000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Total Revenue,11516030000.0
SHILPAMED.NS,income,2024-03-31 00:00:00,Operating Revenue,11516030000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-2037596.069949
SHILPAMED.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.190876
SHILPAMED.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1145418000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Total Unusual Items,-10675000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-10675000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-325332000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,954990000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,4168439000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,EBITDA,1134743000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,EBIT,179753000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Interest Income,-568914000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Interest Expense,562547000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Interest Income,17607000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Normalized Income,-316694596.069949
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-325332000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Total Expenses,10480431000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,10095000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Diluted Average Shares,86801898.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Basic Average Shares,86801898.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Diluted EPS,-3.75
SHILPAMED.NS,income,2023-03-31 00:00:00,Basic EPS,-3.75
SHILPAMED.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-325332000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-325332000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income,-325332000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Minority Interests,-15604000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-309728000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-309728000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Tax Provision,-73066000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Pretax Income,-382794000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,140739000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Special Income Charges,-10675000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Other Special Charges,2648000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Write Off,8027000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-568914000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,23974000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,562547000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,17607000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Operating Income,-45967000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Operating Expense,6311992000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Other Operating Expenses,1608467000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,954990000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,954990000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Research And Development,491023000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Selling General And Administration,321516000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,26225000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,General And Administrative Expense,295291000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,10095000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Gross Profit,6266025000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Cost Of Revenue,4168439000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Total Revenue,10434464000.0
SHILPAMED.NS,income,2023-03-31 00:00:00,Operating Revenue,10434464000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,5299800.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.3
SHILPAMED.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2212339000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Total Unusual Items,17666000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,17666000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,606623000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,798019000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,3840982000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,EBITDA,2230005000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,EBIT,1431986000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Interest Income,-389225000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Interest Expense,409338000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Interest Income,20666000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Normalized Income,594256800.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,606623000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Total Expenses,10142182000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,11594000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Diluted Average Shares,83535734.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Basic Average Shares,83535734.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Diluted EPS,7.26
SHILPAMED.NS,income,2022-03-31 00:00:00,Basic EPS,7.26
SHILPAMED.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,606623000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,606623000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income,606623000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Minority Interests,802000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,605821000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,605821000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Tax Provision,416827000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Pretax Income,1022648000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,107684000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Special Income Charges,17666000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Other Special Charges,-71888000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Write Off,54222000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-389225000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,553000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,409338000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,20666000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Operating Income,1258310000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Operating Expense,6301200000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Other Operating Expenses,1618120000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,798019000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,798019000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Research And Development,550605000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Selling General And Administration,608858000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,56589000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,General And Administrative Expense,552269000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,11594000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Gross Profit,7559510000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Cost Of Revenue,3840982000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Total Revenue,11400492000.0
SHILPAMED.NS,income,2022-03-31 00:00:00,Operating Revenue,11400492000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
SHILPAMED.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
SHILPAMED.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
SHILPAMED.NS,income,2021-03-31 00:00:00,Total Unusual Items,
SHILPAMED.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
SHILPAMED.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
SHILPAMED.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
SHILPAMED.NS,income,2021-03-31 00:00:00,EBITDA,
SHILPAMED.NS,income,2021-03-31 00:00:00,EBIT,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Interest Income,
SHILPAMED.NS,income,2021-03-31 00:00:00,Interest Expense,
SHILPAMED.NS,income,2021-03-31 00:00:00,Interest Income,34375000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Normalized Income,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
SHILPAMED.NS,income,2021-03-31 00:00:00,Total Expenses,
SHILPAMED.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,14606000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
SHILPAMED.NS,income,2021-03-31 00:00:00,Basic Average Shares,
SHILPAMED.NS,income,2021-03-31 00:00:00,Diluted EPS,
SHILPAMED.NS,income,2021-03-31 00:00:00,Basic EPS,
SHILPAMED.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
SHILPAMED.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income,
SHILPAMED.NS,income,2021-03-31 00:00:00,Minority Interests,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
SHILPAMED.NS,income,2021-03-31 00:00:00,Tax Provision,
SHILPAMED.NS,income,2021-03-31 00:00:00,Pretax Income,
SHILPAMED.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
SHILPAMED.NS,income,2021-03-31 00:00:00,Special Income Charges,
SHILPAMED.NS,income,2021-03-31 00:00:00,Other Special Charges,
SHILPAMED.NS,income,2021-03-31 00:00:00,Write Off,
SHILPAMED.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
SHILPAMED.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,1616000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
SHILPAMED.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,34375000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Operating Income,
SHILPAMED.NS,income,2021-03-31 00:00:00,Operating Expense,
SHILPAMED.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
SHILPAMED.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
SHILPAMED.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
SHILPAMED.NS,income,2021-03-31 00:00:00,Research And Development,338090000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Selling General And Administration,476437000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,119230000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,General And Administrative Expense,357207000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,14606000.0
SHILPAMED.NS,income,2021-03-31 00:00:00,Gross Profit,
SHILPAMED.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
SHILPAMED.NS,income,2021-03-31 00:00:00,Total Revenue,
SHILPAMED.NS,income,2021-03-31 00:00:00,Operating Revenue,
